Carole Ho Denali Therapeutics Inc. (DNLI) insider trading activity
Carole Ho is Chief Medical Officer of Denali Therapeutics Inc.. Currently has a direct ownership of 136,655 shares of DNLI, which is worth approximately $3.18 Million. The most recent transaction as insider was on Nov 25, 2024, when has been sold 17,845 shares (Common Stock) at a price of $0.68 per share, resulting in proceeds of $12,134. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
137K
15.02%
3M change
1.66%
12M change
Total Value Held
$3.18 Million
Carole Ho Transaction History
Also insider at
CH
Carole Ho
Chief Medical Officer
Cambridge, MA